AFA Insurance
14
1
3
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
1 terminated/withdrawn out of 14 trials
90.9%
+4.4% vs industry average
0%
0 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
A Professional Development Programme (ProDeveloP) for Newly Graduated Nurses
Role: collaborator
Light in Healthcare Environment (Ljus i sjukhusmiljö)
Role: collaborator
Internet-delivered Cognitive Behavior Therapy for Problematic Alcohol Use in a Working Life Setting
Role: collaborator
Feasibility of a Person-centred Digital Program Targeting Physical Activity in Spinal Stenosis Surgery
Role: collaborator
Nutrition and Inflammation in Patients with Head and Neck Cancer
Role: collaborator
Possible Effects of the Dietary Supplement Magnesium Compared to Placebo
Role: collaborator
A Problem Solving Intervention Involving Employees at Risk of Sick Leave Due to Common Mental Disorders
Role: collaborator
Return to Work in Patients With Chronic Pain
Role: collaborator
CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy
Role: collaborator
Biomarkers in Pain and Pain Treatment
Role: collaborator
A Proactive Intervention Promoting Strategies for Sleep and Recovery in Nurses
Role: collaborator
Smart Phone ACT Treatment for Adults With Longstanding Pain - a Pilot Study
Role: collaborator
Internet-delivered ACT for Chronic Pain
Role: collaborator
CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.
Role: collaborator
All 14 trials loaded